The Immunoglobulin Market to Deliver Improved Profitability in Near Future
Immunoglobulins (IGs) are glycoproteins produced in the blood plasma in response to the antigens, which are foreign to the host system. They are highly complex entities and specific in their action. They are obtained from blood by fractionation process and purified for therapeutic and non-therapeutic applications. In therapeutics, they are administered intravenously in the treatment of various deficiencies. The global immunoglobulin was valued at $8,374 million in 2016, and is projected to reach $13,619 million by 2023, registering a CAGR...
View full press release